|
Dr Trevor Nicholls,
Chief Executive Officer, CABI, United Kingdom
Since joining CABI in 2005, Trevor Nicholls has led the organization to develop a stronger focus on its customers, member countries and funding donors. This market-driven approach has been combined with an integrated communications strategy to present clear messages, both internally and externally about CABI’s core strengths. Internally, operational effectiveness and efficiency have improved so that the organization has delivered four consecutive years of surplus and now benefits from greater financial stability.
Trevor is a professional Company Director who has over 30 years experience of building international businesses in the life science industry, with a focus on genomics, in major pharma, biotech and academic clients. He also has broad experience of initiating change and restructuring organizations, ranging from start-ups to FTSE 100/Nasdaq quoted companies.
Before taking up his current role with CABI, Trevor was Chief Commercial Officer for Affymetrix Inc with accountability for Sales, Marketing, Product Development and Manufacturing. Prior to this, he was founder CEO of Oxagen Ltd where he raised a total of £50 million over three venture-backed financing rounds and secured commercial partnerships in addition to academic collaborations. A major part of Trevor’s early career was with Amersham International (now part of GE Healthcare) covering diagnostics and radiopharmaceuticals as well as research products. He has also worked as a consultant with McKinsey and Company Inc. and in Marketing with Unilever.
Trevor holds a BA and D.Phil in biochemistry from the University of York and diploma qualifications in marketing (CIM) and company directorship. Leisure interests are golf, motorsport, food and wine.
|
|